Clinical Trials

A Clinical Trial to Evaluate the HeartWare Ventricular Assist System (ENDURANCE) - Destination Therapy

Description

Status: Open to Enrollment

Start Date: Aug 01 2010

End Date: OPEN

The HeartWare® VAS is a small, implantable centrifugal pump that was designed to provide flows up to 10 L/min and is surgically placed against the left side of the heart delivering blood from the heart to the rest of the body.   Due to its small size and mechanical simplicity, the HeartWare® Ventricular Assist System may provide benefits not currently available with existing technology. The HeartWare VAS is being evaluated for safety and effectiveness in patients with end-stage heart failure who are ineligible for heart transplantation and thus will have the device for Destination Therapy or life-therapy. The primary endpoint of the trial is stroke-free survival to 2 year with other outcomes including quality of life, functional status improvement, and freedom from adverse events.

Participant Eligibility

Inclusion Criteria:

  1. Must be 18 years of age or older at consent
  2. Body Surface Area (BSA) equal or greater than 1.2 m2
  3. Patients with advanced heart failure symptoms (Class IIIB or IV) who are: (patient must meet one of the following)

a)     On optimal medical management, including dietary salt restriction and diuretics, for at least 45 out of the last 60 days and are failing to respond; or

b)    In Class III or Class IV heart failure for at least 14 days, and dependent on intra aortic balloon pump (IABP) for 7 days and/or inotropes for at least 14 days

  1. Left ventricular ejection fraction < 25%
  2. LVAD implant is intended as destination therapy
  3. Must be able to receive either the HeartWare® VAS or control LVAD
  4. Female patients of childbearing potential must agree to use adequate contraceptive precautions for the duration of the study.
  5. The patient or legally authorized representative has signed the informed consent form 

Principal Investigators

Craig Selzman, M.D.

Contact Information

Name: Erin
Phone: 801-585-3188
Email: erin.davis@hsc.utah.edu

Please Note:

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician. If you do not have a primary care physician, we can help you find a University of Utah doctor or clinic location to meet your health care needs.

Although the studies described on this Web site may have potential benefits as described, the University of Utah and its physicians and affiliated hospitals cannot and do not guarantee or promise that you will receive any benefits from participating in a study.

The information posted on this site is consistent with the research reviewed and approved by the University of Utah Institutional Review Board (IRB). However, the IRB has not reviewed all material posted on this site. Contact the IRB if you have questions regarding your rights as a research participant. Also contact the IRB if you have questions, complaint, or concerns which you do not feel you can discuss with the investigator. The University of Utah IRB may be reached by phone at (801) 581-3655 or by e-mail at irb@hsc.utah.edu.